Ultra low molecular weight heparin: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
'''Editors-in-Chief:''' [[C. Michael Gibson, M.S., M.D.]] '''Associate Editor-In-Chief''': [[User:Ujjwal Rastogi|Ujjwal Rastogi, MBBS]] [mailto:urastogi@perfuse.org]
'''Editors-in-Chief:''' [[C. Michael Gibson, M.S., M.D.]]  
 


==Overview==
==Overview==

Revision as of 18:15, 8 September 2011

Editors-in-Chief: C. Michael Gibson, M.S., M.D.

Overview

AVE5026 is a hemisynthetic, ultra low molecular weight heparin. It is obtained by highly selective and controlled depolymerization of heparin. It has an average molecular weight of 2000 to 3000 Da, as compared to 4000 to 5000 Da of other LMW heparins.


Template:WikiDoc Sources